NutraLife BioSciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of NutraLife BioSciences generated cash of $0, which is more than the previous year. Cash used in financing activities reached the amount of $0 last year.
Cash Flow
| 2013 | -902.48K | -239.00K | 1.06M |
|---|---|---|---|
| 2014 | -1.23M | -27.12K | 1.22M |
| 2015 | -850.67K | -44.92K | 892.7K |
| 2016 | -671.15K | -16.30K | 683K |
| 2017 | -1.01M | -171.11K | 1.35M |
| 2018 | -234.67K | -616.63K | 1.09M |
| 2019 | -2.93M | -1.59M | 4.12M |
| 2020 | -1.28M | 0 | 1.27M |
| 2021 | -487.38K | -675K | 1.29M |
| 2022 | 0 | 0 | 0 |
NLBS Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 135.76K | 742 | 14.82K | 419.97K | 172.94K | 12.13K | 22.14K | 25.05K | 63.25K | 144.75K |
Operating activities | ||||||||||
Net income | 0 | -5.82M | -2.88M | -4.00M | -2.07M | -23.62M | -1.52M | -2.10M | -2.07M | -2.08M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 326.41K | 394.70K | 230.45K | 66.03K | 78.47K | 60.50K | 55.80K | 52.44K | 45.32K |
Stock-based compensation expense | 0 | 2.56M | 501.70K | 610.98K | 0 | 19.01M | 568.75K | 615.82K | 77.31K | 1.27M |
| Deferred income tax benefit | 0 | 2.56M | 501.70K | 610.98K | 0 | 19.01M | 568.75K | 615.82K | 77.31K | 1.27M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 109.99K | -140.89K | 61.20K | -127.68K | -428.15K | -34.9K | 1.18K | 75.43K | -135.18K |
Inventories | 0 | 258.19K | -77.35K | -199.13K | -128.84K | -67.79K | 7.57K | -51.62K | 11.10K | -253.59K |
Accounts payable | 0 | 109.23K | 938 | 22.88K | 187.48K | 68.16K | -10.26K | -968 | -67.74K | 57.93K |
Cash generated by operating activities | 0 | -487.38K | -1.28M | -2.93M | -234.67K | -1.01M | -671.15K | -850.67K | -1.23M | -902.48K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | -1.59M | -581.63K | -171.11K | -16.30K | -44.92K | -27.12K | -239.00K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | -675K | 0 | -1.59M | -616.63K | -171.11K | -16.30K | -44.92K | -27.12K | -239.00K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 348K | 125K | 2.78M | 618.33K | 1.32M | 536.5K | 220.2K | 680K | 615K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -18.91K | -19.58K | 1.34M | 0 | -29.5K | -233K | 672.5K | -25K | -310K |
Cash used in financing activities | 0 | 1.29M | 1.27M | 4.12M | 1.09M | 1.35M | 683K | 892.7K | 1.22M | 1.06M |
Net Change In Cash | 0 | 135.02K | -14.08K | -405.14K | 247.02K | 160.81K | -4.45K | -2.90K | -38.20K | -81.49K |
Cash at end of period | 135.76K | 135.76K | 742 | 14.82K | 419.97K | 172.94K | 17.68K | 22.14K | 25.05K | 63.25K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |